Work

Supplementary Methods, Figure Legends, Table Legend from EGFR Kinase Domain Duplication (EGFR-KDD) Is a Novel Oncogenic Driver in Lung Cancer That Is Clinically Responsive to Afatinib

Year: 2023

Type: supplementary-materials

Abstract: This document contains Supplementary Methods, Supplementary Figure Legends, and Supplementary Table Legend.

DOI: 10.1158/2159-8290.22530765

Authors: Jean-Nicolas Gallant, Jonathan H. Sheehan, Timothy M. Shaver, Mark Bailey, Doron Lipson, Raghu Chandramohan, Monica Red Brewer, Sally J. York, Mark G. Kris, Jennifer A. Pietenpol, Marc Ladanyi, Vincent A. Miller, Siraj M. Ali, Jens Meiler, Christine M. Lovly

Institutions: Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Foundation Medicine (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362616653

Cites:

Cited by:

Related to: 10